Search All UT System Experts

Reduced Risk of hyperkalemia during treatment of heart failure with mineralocorticoid receptor antagonists by use of sacubitril/valsartan compared with enalapril: A secondary analysis of the PARADIGM-HF trial

Akshay S. Desai, Orly Vardeny, Brian Claggett, John J.V. McMurray, Milton Packer, Karl Swedberg, Jean L. Rouleau, Michael R. Zile, Martin Lefkowitz, Victor Shi, Scott D. Solomon

Research output: Contribution to journal › Article › peer-review

143 Scopus citations

Fingerprint

Dive into the research topics of 'Reduced Risk of hyperkalemia during treatment of heart failure with mineralocorticoid receptor antagonists by use of sacubitril/valsartan compared with enalapril: A secondary analysis of the PARADIGM-HF trial'. Together they form a unique fingerprint.

Medicine & Life Sciences